BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang XJ, Qi GT, Zhang XM, Wang L, Li FF. lncRNA RHPN1-AS1 promotes the progression of endometrial cancer through the activation of ERK/MAPK pathway. J Obstet Gynaecol Res 2021;47:533-43. [PMID: 33169491 DOI: 10.1111/jog.14548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Chen Z, Huang M, You J, Lin Y, Huang Q, He C. Circular RNA hsa_circ_0023404 promotes the proliferation, migration and invasion in endometrial cancer cells through regulating miR-217/MAPK1 axis. Eur J Med Res 2022;27:242. [DOI: 10.1186/s40001-022-00866-x] [Reference Citation Analysis]
2 Cui S. METTL3 ‐mediated m6A modification of lnc RNA RHPN1‐AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K / AKT pathway. Clinical Laboratory Analysis 2022. [DOI: 10.1002/jcla.24761] [Reference Citation Analysis]
3 Lu B, Wu J, Chen H, Li S, Jia K. LncRNA Expression Profiles in Canine Mammary Tumors Identify lnc34977 as a Promoter of Proliferation, Migration and Invasion of Canine Mammary Tumor Cells. Veterinary Sciences 2022;9:82. [DOI: 10.3390/vetsci9020082] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zhang Y, Zhao W, Na F, Li M, Tong S. LINC01354/microRNA-216b/KRAS Axis Promotes the Occurrence and Metastasis of Endometrial Cancer. Nanoscale Res Lett 2022;17:21. [PMID: 35099637 DOI: 10.1186/s11671-021-03640-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhou Y, Li J, Yang X, Song Y, Li H. Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (TOP2A). Bioengineered 2021;12:12003-22. [PMID: 34787052 DOI: 10.1080/21655979.2021.2002494] [Reference Citation Analysis]
6 Zhu L, Mei M. Interference of long non-coding RNA HAGLROS inhibits the proliferation and promotes the apoptosis of ovarian cancer cells by targeting miR-26b-5p. Exp Ther Med 2021;22:879. [PMID: 34194557 DOI: 10.3892/etm.2021.10311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]